Document is current
Any future updates will be listed below
-
Authors
Luo, Dakui
Chen, Min
Li, Qingguo
Wang, Kangjunjie
Wang, Kaihua
Li, Junqiang
Fu, Guoxiang
Shan, Zezhi
Liu, Qi
Yang, Yufei
Liang, Lei
Ma, Yanlei
Qin, Yi
Qin, Jun
Gao, Daming
Li, Xinxiang
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82103259, 81972260, 81925029, 82230098, 32221002, 81790253, 82103259, 81972260, 81925029, 82230098, 32221002, 81790253, 82103259, 81972260, 81925029, 82230098, 32221002, 81790253)
National Key Research and Development Program of China (2020YFA0803203 and 2019YFA0802102)
CAS Interdisciplinary Innovation Team and the Shanghai Municipal Science and Technology Major Project (JCTD-2018-14)
- License Information
-
More Information
Article History
Received: 13 April 2023
Accepted: 25 August 2023
First Online: 7 September 2023
Declarations
:
: All animal experiments were approved by the Institutional Animal Care and Use Committee of the Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. The CRC specimens were obtained from patients who underwent surgery at Fudan University Shanghai Cancer Center. The study protocol was approved by the Ethics Committee of Fudan University Shanghai Cancer Center.
: Not applicable.
: Junqiang Li has ownership of D1 Medical Technology (Shanghai) Co., Ltd, Shanghai. Other authors do not have any competing interest.
